Healthcare - Sector
REPL is currently covered by 6 analysts with an average price target of $12.3. This is a potential downside of $6.77 (-35.5%) from yesterday's end of day stock price of $19.07.
Replimune Group's activity chart (see below) currently has 137 price targets and 124 ratings on display. The stock rating distribution of REPL is 53.33% BUY, 40% HOLD and 6.67% SELL.
Analysts' price targets on this stock were met 51.58% of the time, taking 246.55 days on average.
Highest price target for REPL is $27, Lowest price target is $2, average price target is $12.3.
Most recent stock forecast was given by ALLISON BRATZEL from PIPER SANDLER. First documented stock forecast 14-Aug-2018.
Currently out of the existing stock ratings of REPL, 8 are a BUY (53.33%), 6 are a HOLD (40%), 1 are a SELL (6.67%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 04-Feb-2026
$27
$7.93 (41.58%)
$14
5 days ago
(15-Nov-2026)
Buy Since 07-Aug-2026
$21
$1.93 (10.12%)
$20
2 months 26 days ago
(26-Aug-2026)
16/18 (88.89%)
$5.12 (32.24%)
457
Hold Since 07-Aug-2026
$19
$-0.07 (-0.37%)
3 months 14 days ago
(07-Aug-2026)
10/15 (66.67%)
$6.94 (57.55%)
350
Hold Since 13-Apr-2026
$17
$-2.07 (-10.85%)
3 months 17 days ago
(04-Aug-2026)
5/11 (45.45%)
$5.08 (42.62%)
287
Buy Since 02-Nov-2020
$2
$-9.63 (-82.80%)
$8
7 months 8 days ago
(13-Apr-2026)
2/4 (50%)
$-2.76 (-57.98%)
36
What is REPL (Replimune Group) average time for price targets to be met?
Which analyst most recently updated their price target on REPL (Replimune Group)?
Which analyst has the most public recommendations on REPL (Replimune Group)?
Which analyst is the currently most bullish on REPL (Replimune Group)?
Which analyst is the currently most reserved on REPL (Replimune Group)?